To understand how PROM1 expression is regulated in CD133+ MLLr leukemias, we analyzed ChIP-seq datasets from multiple cell types, using MLL-N and AF4-C binding as a proxy for MLL-AF4 fusion protein binding. Here, KMT2A is linked to leukemia.